サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1672213

アミノ酸代謝障害治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Amino Acid Metabolism Disorders Treatment Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 127 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
アミノ酸代謝障害治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 127 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アミノ酸代謝障害治療の世界市場規模は、2024年の7億6,000万米ドルから2033年には11億7,000万米ドルに成長し、2026～2033年の予測期間中に4.97％の堅調な年間平均成長率（CAGR）を示すと予測されます。

アミノ酸代謝障害治療市場は、遺伝学的研究と個別化医療の進歩に牽引され、大きな進化を遂げようとしています。代謝経路の理解が深まるにつれ、酵素補充療法や遺伝子編集技術など、革新的な治療アプローチが出現しています。これらの進歩は、治療効果の向上を約束するだけでなく、副作用を最小限に抑えることで、患者のコンプライアンスと転帰を改善することを目指しています。

アミノ酸代謝異常の有病率の増加は、遺伝子検査に対する意識の高まりと相まって、市場成長の触媒となっています。医療プロバイダーは、個人の遺伝子プロファイルに基づいて治療を調整する精密医療戦略を採用するようになってきています。このシフトは、単に症状を管理するのではなく、これらの疾患の根本的な原因に対処する標的療法の開発を促進すると予想されます。さらに、製薬会社と研究機関の協力により、新規化合物の発見が加速され、臨床医が利用できる治療手段が拡大すると考えられます。

規制当局もまた、このセグメントにおける技術革新の急速なペースに適応し、新しい治療法の承認プロセスを合理化しています。こうした規制当局の支援とバイオテクノロジーへの投資の高まりが相まって、市場拡大のための環境が整いつつあると予想されます。希少疾患への注目が高まるにつれ、利害関係者はアンメット・メディカル・ニーズへの対応を目的とした研究開発イニシアティブへの資金提供の急増を目の当たりにすると考えられます。その結果、アミノ酸代謝障害治療市場は、治療選択肢の強化と患者ケアの改善を特徴とする変革期を迎えようとしています。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために綿密に作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 アミノ酸代謝異常治療産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 アミノ酸代謝異常治療の世界市場分析：適応症別

  • 適応症別概要
  • 適応症別過去・予測データ分析
  • フェニルケトン尿症
  • メープルシロップ尿症
  • シトルリン血症
  • ホモシスチン尿症
  • アルギニノコハク酸尿症

第6章 アミノ酸代謝異常症治療の世界市場分析：製品別

  • 製品別概要
  • 製品別過去・予測データ分析
  • 葉酸
  • ビタミンB6とビタミンB12
  • アルギニン
  • チアミン
  • ベタイン
  • サプロプテリン
  • その他

第7章 世界のアミノ酸代謝異常治療市場分析：流通チャネル別

  • 流通チャネル別概要
  • 流通チャネル別過去・予測データ分析
  • 病院薬局
  • ドラッグストアと小売薬局
  • オンラインプロバイダー

第8章 アミノ酸代謝異常治療の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 アミノ酸代謝異常治療企業の競合情勢

  • アミノ酸代謝異常治療市場競争
  • 提携・協力・契約
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Amino GmbH
  • Kyowa Hakko Kirin Co. Ltd.
  • Sanofi
  • Recordati S.P.A.
  • GlaxoSmithKline PLC
  • Koninklijke DSM N.V.
  • BioMarin Pharmaceutical Inc.
  • Civentichem LLC Ltd.
  • Merck KGaA
  • Shine Star（Hubei）Biological Engineering Co.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Indication (USD MN)
  • Phenylketonuria Market Sales By Geography (USD MN)
  • Maple Syrup Urine Disease Market Sales By Geography (USD MN)
  • Citrullinemia Market Sales By Geography (USD MN)
  • Homocystinuria Market Sales By Geography (USD MN)
  • Argininosuccinic Aciduria Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Folic Acid Market Sales By Geography (USD MN)
  • Vitamin B6 and B12 Market Sales By Geography (USD MN)
  • Arginine Market Sales By Geography (USD MN)
  • Thiamine Market Sales By Geography (USD MN)
  • Betaine Market Sales By Geography (USD MN)
  • Sapropterin Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Drug Stores and Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Providers Market Sales By Geography (USD MN)
  • Global Amino Acid Metabolism Disorders Treatment Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Amino Acid Metabolism Disorders Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Amino Acid Metabolism Disorders Treatment Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Indication (USD MN)
  • Phenylketonuria Market Sales By Geography (USD MN)
  • Maple Syrup Urine Disease Market Sales By Geography (USD MN)
  • Citrullinemia Market Sales By Geography (USD MN)
  • Homocystinuria Market Sales By Geography (USD MN)
  • Argininosuccinic Aciduria Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Folic Acid Market Sales By Geography (USD MN)
  • Vitamin B6 and B12 Market Sales By Geography (USD MN)
  • Arginine Market Sales By Geography (USD MN)
  • Thiamine Market Sales By Geography (USD MN)
  • Betaine Market Sales By Geography (USD MN)
  • Sapropterin Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Drug Stores and Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Providers Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11218237

Global Amino Acid Metabolism Disorders Treatment Market size is anticipated to grow from USD 0.76 Billion in 2024 to USD 1.17 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 4.97% during the forecast period of 2026 to 2033.

The landscape of the amino acid metabolism disorders treatment market is poised for significant evolution, driven by advancements in genetic research and personalized medicine. As the understanding of metabolic pathways deepens, innovative therapeutic approaches are emerging, including enzyme replacement therapies and gene editing technologies. These advancements not only promise to enhance treatment efficacy but also aim to minimize adverse effects, thereby improving patient compliance and outcomes.

The increasing prevalence of amino acid metabolism disorders, coupled with a growing awareness of genetic testing, is catalyzing market growth. Healthcare providers are increasingly adopting precision medicine strategies, tailoring treatments based on individual genetic profiles. This shift is expected to foster the development of targeted therapies that address the underlying causes of these disorders rather than merely managing symptoms. Furthermore, collaborations between pharmaceutical companies and research institutions are likely to accelerate the discovery of novel compounds, expanding the therapeutic arsenal available to clinicians.

Regulatory bodies are also adapting to the rapid pace of innovation in this field, streamlining approval processes for new therapies. This regulatory support, combined with rising investments in biotechnology, is expected to create a conducive environment for market expansion. As the focus on rare diseases intensifies, stakeholders are likely to witness a surge in funding for research and development initiatives aimed at addressing unmet medical needs. Consequently, the amino acid metabolism disorders treatment market is on the brink of a transformative phase, characterized by enhanced therapeutic options and improved patient care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Indication

  • Phenylketonuria
  • Maple Syrup Urine Disease
  • Citrullinemia
  • Homocystinuria
  • Argininosuccinic Aciduria

By Product

  • Folic Acid
  • Vitamin B6 and B12
  • Arginine
  • Thiamine
  • Betaine
  • Sapropterin
  • Others

By Distribution channel

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers
  • COMPANIES PROFILED
  • AMINO GmbH
  • Kyowa Hakko Kirin Co. Ltd.
  • Sanofi
  • Recordati S.p.A.
  • GlaxoSmithKline PLC
  • Koninklijke DSM N.V.
  • BioMarin Pharmaceutical Inc.
  • Civentichem LLC Ltd.
  • Merck KGaA
  • Shine Star (Hubei) Biological Engineering Co.
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. AMINO ACID METABOLISM DISORDERS TREATMENT INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Indication
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY INDICATION

  • 5.1. Overview By Indication
  • 5.2. Historical and Forecast Data Analysis By Indication
  • 5.3. Phenylketonuria Historic and Forecast Sales By Regions
  • 5.4. Maple Syrup Urine Disease Historic and Forecast Sales By Regions
  • 5.5. Citrullinemia Historic and Forecast Sales By Regions
  • 5.6. Homocystinuria Historic and Forecast Sales By Regions
  • 5.7. Argininosuccinic Aciduria Historic and Forecast Sales By Regions

6. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Folic Acid Historic and Forecast Sales By Regions
  • 6.4. Vitamin B6 and B12 Historic and Forecast Sales By Regions
  • 6.5. Arginine Historic and Forecast Sales By Regions
  • 6.6. Thiamine Historic and Forecast Sales By Regions
  • 6.7. Betaine Historic and Forecast Sales By Regions
  • 6.8. Sapropterin Historic and Forecast Sales By Regions
  • 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.4. Drug Stores and Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Online Providers Historic and Forecast Sales By Regions

8. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE AMINO ACID METABOLISM DISORDERS TREATMENT COMPANIES

  • 9.1. Amino Acid Metabolism Disorders Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF AMINO ACID METABOLISM DISORDERS TREATMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Amino GmbH
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Kyowa Hakko Kirin Co. Ltd.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Sanofi
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Recordati S.P.A.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. GlaxoSmithKline PLC
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Koninklijke DSM N.V.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. BioMarin Pharmaceutical Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Civentichem LLC Ltd.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Merck KGaA
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Shine Star (Hubei) Biological Engineering Co.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Teva Pharmaceutical Industries Ltd.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Pfizer Inc
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies